Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer

Source
Clinical cancer research - ISSN 1078-0432-29:3 (2023) p. 635-646